Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Cross-border treatment and management experience of voretigene neparvovec (ocular gene therapy) in the European Union

Author: Mirjana Bjelos (Croatia)

Co-authors: Gabriella Germán, Natalia Filimonova, Beata Busanyova

Purpose

Voretigene neparvovec (VN) is the first ocular gene therapy approved for the treatment of patients with visual impairment due to confirmed biallelic RPE65 mutation-associated inherited retinal dystrophy (IRD) and who have sufficient viable retinal cells. Due to the novelty of the treatment and the limited number of patients, VN is administered in treatment centers that fulfill specified European Union (EU)-mandated risk mitigation criteria. This also ensures that safety and efficacy are kept a top priority. EU regulation and directive furthermore govern planned cross-border interventions, under which a patient may travel to another EU country to receive treatment, and have the cost reimbursed by their own health insurance scheme. Herein, we present the experience of, and coordination between, a VN treatment center in Croatia and a patient management center in Slovakia.

Setting/Venue

Cross-border ocular gene therapy treatment and management between the University Eye Department, University Hospital “Sveti Duh”, Zagreb (UEDUHSDZ), Croatia and the National Institute of Children’s Diseases (NICHD), Faculty of Medicine, Comenius University, Bratislava, Slovakia, following S2 form authorization. The S2 (formerly E 112) form is issued by the health insurance authority in the patient’s home country to permit planned healthcare treatment in another EU country. The form is then submitted to the health insurance authority in the treating country.

Methods

The IRD registry at the NICHD, Slovakia was retrospectively evaluated to identify patients diagnosed with IRD owing to RPE65 mutations, as confirmed by genetic analysis and segregation analysis of first degree relatives. Five pediatric patients were identified, with two patients subsequently recommended as suitable for VN treatment following examination of visual acuity (VA), fundoscopy, wide-field fundus photography (WFFP), autofluorescence, perimetry, optical coherence tomography (OCT), color vision (CV), contrast sensitivity (CS), visually evoked potentials (VEP), electroretinography (ERG), tonometry, biometry, refraction and a visual function questionnaire. Three certified VN treatment centers in the EU were contacted to participate in the cross-border care of the two NICHD patients. UEDUHSDZ, Croatia accepted NICHD’s treatment application and a cross-border treatment agreement was established. As VN treatment is covered by health insurance in Slovakia, prior reimbursement authorization was requested and a S2 form was issued. Patients were referred to the multidisciplinary team in UEDUHSDZ, which comprises a pediatric ophthalmologist, an IRD specialist, three retinal surgeons with experience in subretinal application and a geneticist. Surgery was scheduled in Croatia in December 2020, with patients enrolled in PERCEIVE (a post-authorization, multicenter, multinational, longitudinal, observational safety registry study for patients treated with VN) by their managing physician in Slovakia.

Results

Following a negative COVID-19 PCR test, both patients were admitted to UEDUHSDZ four days prior to their scheduled surgical procedure. Patients were examined by the multidisciplinary team in UEDUHSDZ, with WFFP, autofluorescence, biometry, tonometry and OCT performed to confirm eligibility for VN treatment. An immunomodulatory regimen was subsequently initiated in accordance with the recommended VN product information pre-operative schedule. On day four, patients received 300 μl of VN in the first (more severely affected) eye, followed by treatment of the contralateral eye, one week later. Post-surgery, information on the procedure was immediately communicated to NICHD to update the PERCEIVE registry. Patients were discharged from UEDUHSDZ four days after their second surgery and presented to NICHD 30 days post-operatively for follow-up clinical examinations. Follow-up assessment revealed a significant improvement in central visual acuity in one of the two patients, with both patients reporting an improvement in quality of life. No adverse events were observed. The patients will be further followed by NICHD at month 3, month 6 and 1 year.

Conlusions

A willingness to collaborate, straightforward funding arrangements and positive relations between the Croatian and Slovakian teams contributed to the successful cross-border treatment and management of patients. In this case example, patients were diagnosed with biallelic RPE65 mutation-associated IRDs by the multidisciplinary team at the NICHD, Bratislava and referred to UEDUHSDZ, Croatia for VN surgical treatment. Following successful gene therapy administration in UEDUHSDZ, patients were discharged and returned to Bratislava for post-operative follow-up at the NICHD. Communication and collaboration between UEDUHSDZ and NICHD was seamless and efficient, with a positive cross-border experience reported by the patients, families and both multidisciplinary teams. Due to treatment and management center cooperation and positive collaboration, a further three patients from the NICHD IRD registry will be evaluated for cross-border VN treatment.

Financial Disclosure

Mirjana Bjeloš: Voretigene neparvovec post-authorisation safety study (PASS) principle investigator; Beata Busanyova: Voretigene neparvovec post-authorisation safety study (PASS) principle investigator; Natalia Filimonova: Employee of Novartis; Gabriella Germán: Employee of Novartis

Comments

-
PrevPrevious
NextNext
Euretina Logo, Links to homepage.

European Society of Retina Specialists c/o Congrex Switzerland
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

General Enquires: [email protected]

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2026 All rights reserved

  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login